Correspondence 0001493152-23-045470 from IB Acquisition Corp. (IBAC, IBACR) (CIK 0001998781) (IBAC)
IB Acquisition Corp. (IBAC, IBACR) (CIK 0001998781)
Date: Dec. 19, 2023 · CIK: 0001998781 · Accession: 0001493152-23-045470
AI Filing Summary & Sentiment
File numbers found in text: 333-275650
Show Raw Text
CORRESP
1
filename1.htm
December
19, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Real Estate and Construction
100
F Street, NE
Washington,
DC 20549
Attention:
Stacie Gorman
Re:
IB
Acquisition Corp.
Registration
Statement on Form S-1
Filed
November 17, 2023
File
No. 333-275650
Ladies
and Gentlemen:
This
letter is being submitted on behalf of IB Acquisition Corp. (the “Company”) in response to the comment letter, dated
December 14, 2023, of the staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange
Commission (the “Commission”) with respect to the Registration Statement on Form S-1 filed on November 17, 2023 (the
“Registration Statement”). The Company’s amended Registration Statement (the “Amended Registration
Statement”) has been filed with the Commission.
Registration
Statement on Form S- 1
Cover
Page
1.
We note your disclosure that you will have 18 months from the closing of the initial public
offering to consummate your initial business combination. Please clarify, if true, that you may amend your organizational documents to
extend your business combination deadline. If there are reasons why you cannot or will not seek shareholder approval to extend such deadline,
please state so. Please add similar clarification elsewhere in your filing where you describe the deadline.
RESPONSE:
The
cover page of the prospectus in the Amended Registration Statement, as well as elsewhere in the filing, have been revised to address
the Staff’s comment.
2.
We note your disclosure on page 8 that the board could determine to modify your bylaws to “reduce the number of shares
required to be present at a meeting of our stockholders” and that this would result in it being significantly more likely that
your initial business combination would be approved. Please revise the cover page to reflect this option. Further, we note your
disclosure that “if only the minimum number of stockholders required to be present ... are present at such meeting, in
addition to the founder shares and private placement shares held by our sponsor and the 350,000 Representative shares held by
I-Bankers, we would not need any of the 10,000,000 public shares to be voted in favor of our initial business combination in order
to have such transaction approved.” Please also revise the cover to reflect this disclosure.
RESPONSE:
The
cover page of the prospectus in the Amended Registration Statement has been revised to address the Staff’s comment.
United States Securities and Exchange Commission
December 19, 2023
Page 2
The
Offering
Redemption
rights for public stockholders . . ., page 11
3.
We note your statement that your public shareholders will have the opportunity to redeem their shares upon the completion of your
business combination. Please revise here, and elsewhere, to disclose whether the shareholders will be permitted to redeem their
shares regardless of whether they abstain, vote for, or against, the proposed transaction or whether they must vote against
it.
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
Conflicts
of Interest, page 16
4.
Please expand your discussion regarding how certain of your sponsor’s members are associated with I-Bankers to also disclose
the M&A fee and finder fee.
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
Risk
Factors
We
may engage our underwriters or one of their respective affiliates..., page 20
5.
Please revise to reconcile your disclosure here, which states that you “may” engage your underwriter or their affiliates
to provide additional services such as arranging debt financing transactions, with your disclosures elsewhere, including your
disclosure on page 93 that you have already engaged I-Bankers to assist you with various matters, including to introduce you to
potential investors. You also state that you will pay I-Bankers a finder fee of 1% of the consideration issued to the target. Please
revise your disclosures throughout, including your discussions regarding conflicts of interest, to also highlight this fee. We also
note your disclosure that fees paid to your underwriter or its affiliates will be based on arm’s length negotiations. Given
the significant relationship between you and your underwriter, please revise to describe the negotiations resulting in these fees,
and explain why you consider such negotiations were conducted on an arm’s length basis. State whether Ms. Panigone was
involved with such negotiations (as we note your disclosure of her former experience with I-Bankers), and explain how any future
negotiations will be conducted on an arm’s length basis. Additionally, please expand the risk factor to disclose the risks
associated with negotiating with your affiliated entities.
RESPONSE: The
Amended Registration Statement has been amended to address the Staff’s comment.
We
may be unable to obtain additional financing to complete our initial business combination..., page 32
6.
Please revise to reconcile your statement here that you believe the net proceeds of this offering and the sale of the private
placement units will be sufficient to allow you to complete your business combination, with your disclosures elsewhere stating that
you anticipate targeting a business with an enterprise value of at least $500 million. Also, clearly disclose the impact of any
future financings to you and investors. To the extent you may utilize PIPE transactions, disclose that the agreements are intended
to ensure a return on investment to the investor in return for funds facilitating the sponsor’s completion of the business
combination or providing sufficient liquidity. Please also disclose that these arrangements result in costs particular to the
de-SPAC process that would not be anticipated in a traditional IPO. Additionally, clarify how you expect to pay for the M&A fee
and the finder fee.
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
United States Securities and Exchange Commission
December 19, 2023
Page 3
Provisions
in our amended and restated articles of incorporation and Nevada law..., page 46
7.
Please revise your introductory paragraph to highlight the forum provision discussed in the risk factor. Additionally, please expand
to address the forum provision applicable to your rights, as discussed on page 97.
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
Management,
page 83
8.
Please provide disclosure regarding Feng Xiangkun’s experience pursuant to Items 401(c) and (e) of Regulation S-K or otherwise
advise. In addition, we note your statements that each of your officers and directors are members of your sponsor, that Ms. Panigone
formerly worked at I-Bankers Direct, and that certain members of your sponsor are “associated persons” of I-Bankers and
that these members own approximately over 52% of your sponsor. Please revise to clarify when her experience with I-Bankers
occurred.
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
Principal
Stockholders, page 90
9.
We note your statement that Shelley Leonard is the manager of your sponsor. Please revise to clarify whether she exercises the
voting and/or dispositive control with respect to the securities owned by I-B Good Works 4, LLC, and if not, please revise to
disclose such natural person(s).
RESPONSE:
The
Amended Registration Statement has been amended to address the Staff’s comment.
* * *
* * *
United States Securities and Exchange Commission
December 19, 2023
Page 4
Should
you have any questions regarding the foregoing, please do not hesitate to contact Cavas Pavri at (202) 724-6847.
Sincerely,
ARENTFOX
SCHIFF LLP
/s/
Cavas Pavri
By:
Cavas
Pavri
Enclosures
cc:
Al
Lopez, CEO, IB Acquisition Corp.
Ralph
V. De Martino, ArentFox Schiff LLP